Why Calix, Imugene, Legacy Iron Ore, and Lovisa shares are charging higher

These ASX shares are on form today…

| More on:
green arrow representing a rise in the share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and tumbling lower. At the time of writing, the benchmark index is down 0.7% to 7,416.2 points.

Four ASX shares that have not let that hold them back are listed below. Here's why they are charging higher:

Calix Ltd (ASX: CXL)

The Calix share price is up 6% to $7.59. This follows the release of the environmental technology company's annual general meeting presentation. That presentation talked up the company's development of multiple environmental business opportunities. Management estimates that it has several billion dollar plus opportunities.

Imugene Limited (ASX: IMU)

The Imugene share price is up 5.5% to 60.7 cents. This morning the immuno-oncology focused biopharmaceutical company announced a new clinical trial supply agreement with Merck and Pfizer. The parties intend to work together to evaluate the safety and efficacy of Imugene's HER-Vaxx when combined with avelumab in patients with HER-2 positive gastric cancer.

Legacy Iron Ore Limited (ASX: LCY)

The Legacy Iron Ore share price has jumped 84% to 3.5 cents. This follows news that the iron ore explorer has signed an agreement with a subsidiary of Gina Rinehart's Hancock Prospecting for the Mt Bevan iron ore project. This project is owned 60:40 by Legacy Iron Ore and Hawthorn Resources Limited (ASX: HAW). Hancock Magnetite has agreed to an earn-in under a subsequent joint venture agreement to develop the project.

Lovisa Holdings Ltd (ASX: LOV)

The Lovisa share price is up 1.5% to $21.94. Investors have been buying this fashion jewellery retailer's shares after Macquarie upgraded them to an outperform rating with an improved price target of $25.00. The broker sees a very big opportunity for Lovisa in the China and India markets. Its analysts also believe the company's new CEO is a great fit.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »